These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 9631236

  • 1. Signaling role of PDE isozymes in pathobiology of glomerular mesangial cells. Studies in vitro and in vivo.
    Dousa TP.
    Cell Biochem Biophys; 1998; 29(1-2):19-34. PubMed ID: 9631236
    [Abstract] [Full Text] [Related]

  • 2. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis.
    Chini CC, Grande JP, Chini EN, Dousa TP.
    J Biol Chem; 1997 Apr 11; 272(15):9854-9. PubMed ID: 9092521
    [Abstract] [Full Text] [Related]

  • 3. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.
    Matousovic K, Grande JP, Chini CC, Chini EN, Dousa TP.
    J Clin Invest; 1995 Jul 11; 96(1):401-10. PubMed ID: 7615811
    [Abstract] [Full Text] [Related]

  • 4. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
    Tsuboi Y, Shankland SJ, Grande JP, Walker HJ, Johnson RJ, Dousa TP.
    J Clin Invest; 1996 Jul 15; 98(2):262-70. PubMed ID: 8755633
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4.
    Cheng J, Thompson MA, Walker HJ, Gray CE, Diaz Encarnacion MM, Warner GM, Grande JP.
    Am J Physiol Renal Physiol; 2004 Nov 15; 287(5):F940-53. PubMed ID: 15280158
    [Abstract] [Full Text] [Related]

  • 6. Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway.
    Chini EN, Chini CC, Bolliger C, Jougasaki M, Grande JP, Burnett JC, Dousa TP.
    Kidney Int; 1997 Oct 15; 52(4):917-25. PubMed ID: 9328930
    [Abstract] [Full Text] [Related]

  • 7. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
    Chini CC, Chini EN, Williams JM, Matousovic K, Dousa TP.
    Kidney Int; 1994 Jul 15; 46(1):28-36. PubMed ID: 7933846
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
    Matousovic K, Tsuboi Y, Walker H, Grande JP, Dousa TP.
    J Lab Clin Med; 1997 Nov 15; 130(5):487-95. PubMed ID: 9390636
    [Abstract] [Full Text] [Related]

  • 10. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway.
    Chini EN, Choi E, Grande JP, Burnett JC, Dousa TP.
    Biochem Biophys Res Commun; 1995 Oct 24; 215(3):868-73. PubMed ID: 7488054
    [Abstract] [Full Text] [Related]

  • 11. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S, Daniel C, Schulze-Lohoff E, Bäumert HG, Lambrecht G, Hugo C.
    Kidney Int; 2002 Nov 24; 62(5):1659-71. PubMed ID: 12371966
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide-induced F-actin disassembly is mediated via cGMP, cAMP, and protein kinase A activation in rat mesangial cells.
    Sandau KB, Gantner F, Brüne B.
    Exp Cell Res; 2001 Dec 10; 271(2):329-36. PubMed ID: 11716545
    [Abstract] [Full Text] [Related]

  • 13. Role of cyclins in cAMP inhibition of glomerular mesangial cell proliferation.
    Ito C, Yamamoto H, Furukawa Y, Takeda S, Akimoto T, Iimura O, Ando Y, Asano Y, Kusano E.
    Clin Sci (Lond); 2004 Jul 10; 107(1):81-7. PubMed ID: 14992682
    [Abstract] [Full Text] [Related]

  • 14. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
    Bian JS, Zhang WM, Pei JM, Wong TM.
    J Pharmacol Exp Ther; 2000 Mar 10; 292(3):1065-70. PubMed ID: 10688624
    [Abstract] [Full Text] [Related]

  • 15. Lysophosphatidic acid and mesangial cells: implications for renal diseases.
    Inoue CN, Epstein M, Forster HG, Hotta O, Kondo Y, Iinuma K.
    Clin Sci (Lond); 1999 Apr 10; 96(4):431-6. PubMed ID: 10087253
    [Abstract] [Full Text] [Related]

  • 16. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
    Dousa TP.
    Kidney Int; 1999 Jan 10; 55(1):29-62. PubMed ID: 9893113
    [Abstract] [Full Text] [Related]

  • 17. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG, Sage EH.
    J Cell Biochem; 2003 Mar 01; 88(4):802-11. PubMed ID: 12577314
    [Abstract] [Full Text] [Related]

  • 18. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
    Wu ZL, Wang YC, Zhou Q, Ge YQ, Lan Y.
    Cell Biochem Funct; 2003 Sep 01; 21(3):249-56. PubMed ID: 12910478
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J, Hiramatsu N, Zhu Y, Morioka T, Takeda M, Oite T, Kitamura M.
    J Am Soc Nephrol; 2005 Jan 01; 16(1):58-67. PubMed ID: 15537869
    [Abstract] [Full Text] [Related]

  • 20. Study on the signalling pathway of inhibitory effect of adreno-medullin on the growth of cultured glomerular mesangial cells.
    Liu XG, Dai L, Yang C, Zhao ZH, Zhang XR, Zhang ZG, Guo MY.
    Chin Med J (Engl); 2005 Aug 20; 118(16):1374-9. PubMed ID: 16157033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.